Targeted disruption of the mouse beta 1-adrenergic receptor gene: Developmental and cardiovascular effects

被引:237
作者
Rohrer, DK
Desai, KH
Jasper, JR
Stevens, ME
Regula, DP
Barsh, GS
Bernstein, D
Kobilka, BK
机构
[1] STANFORD UNIV, HOWARD HUGHES MED INST, DEPT MOL & CELLULAR PHYS, STANFORD, CA 94305 USA
[2] STANFORD UNIV, DEPT PEDIAT, STANFORD, CA 94305 USA
[3] UNIV CALIF BERKELEY, LAWRENCE BERKELEY LAB, DIV LIFE SCI, BERKELEY, CA 94720 USA
[4] ROCHE INST BIOL SCI, PALO ALTO, CA 94304 USA
[5] STANFORD UNIV, DEPT PATHOL, STANFORD, CA 94305 USA
[6] STANFORD UNIV, HOWARD HUGHES MED INST, DEPT GENET, STANFORD, CA 94305 USA
关键词
D O I
10.1073/pnas.93.14.7375
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
At least three distinct beta-adrenergic receptor (beta-AR) subtypes exist in mammals. These receptors modulate a wide variety of processes, from development and behavior, to cardiac function, metabolism, and smooth muscle tone. To understand the roles that individual beta-AR subtypes play in these processes, we have used the technique of gene targeting to create homozygous beta 1-AR null mutants (beta 1-AR -/-) in mice. The majority of beta 1-AR -/- mice die prenatally, and the penetrance of lethality shows strain dependence. beta 1-AR -/- mice that do survive to adulthood appear normal, but lack the chronotropic and inotropic responses seen in wild-type mice when beta-AR agonists such as isoproterenol are administered. Moreover, this lack of responsiveness is accompanied by markedly reduced stimulation of adenylate cyclase in cardiac membranes from beta 1-AR -/- mice. These findings occur despite persistent cardiac beta 2-AR expression, demonstrating the importance of beta 1-ARs for proper mouse development and cardiac function, while highlighting functional differences between beta-AR subtypes.
引用
收藏
页码:7375 / 7380
页数:6
相关论文
共 30 条
[1]  
[Anonymous], PHARM BASIS THERAPEU
[2]   QUANTIFICATION OF BETA-ADRENOCEPTORS AND BETA-ADRENOCEPTOR KINASE ON PROTEIN AND MESSENGER-RNA LEVELS IN HEART-FAILURE [J].
BOHM, M ;
LOHSE, MJ .
EUROPEAN HEART JOURNAL, 1994, 15 :30-34
[3]  
BRISTOW MR, 1989, MOL PHARMACOL, V35, P295
[4]  
BROADLEY KJ, 1984, METHOD FIND EXP CLIN, V6, P179
[5]  
BRODDE OE, 1991, PHARMACOL REV, V43, P203
[6]   COEXISTENCE OF FUNCTIONING BETA(1)-ADRENOCEPTOR AND BETA(2)-ADRENOCEPTOR IN SINGLE MYOCYTES FROM HUMAN VENTRICLE [J].
DELMONTE, F ;
KAUMANN, AJ ;
POOLEWILSON, PA ;
WYNNE, DG ;
PEPPER, J ;
HARDING, SE .
CIRCULATION, 1993, 88 (03) :854-863
[7]   CLONING OF THE GENE AND CDNA FOR MAMMALIAN BETA-ADRENERGIC-RECEPTOR AND HOMOLOGY WITH RHODOPSIN [J].
DIXON, RAF ;
KOBILKA, BK ;
STRADER, DJ ;
BENOVIC, JL ;
DOHLMAN, HG ;
FRIELLE, T ;
BOLANOWSKI, MA ;
BENNETT, CD ;
RANDS, E ;
DIEHL, RE ;
MUMFORD, RA ;
SLATER, EE ;
SIGAL, IS ;
CARON, MG ;
LEFKOWITZ, RJ ;
STRADER, CD .
NATURE, 1986, 321 (6065) :75-79
[8]   MOLECULAR CHARACTERIZATION OF THE HUMAN BETA-3-ADRENERGIC RECEPTOR [J].
EMORINE, LJ ;
MARULLO, S ;
BRIENDSUTREN, MM ;
PATEY, G ;
TATE, K ;
DELAVIERKLUTCHKO, C ;
STROSBERG, AD .
SCIENCE, 1989, 245 (4922) :1118-1121
[9]   CLONING OF THE CDNA FOR THE HUMAN BETA-1-ADRENERGIC RECEPTOR [J].
FRIELLE, T ;
COLLINS, S ;
DANIEL, KW ;
CARON, MG ;
LEFKOWITZ, RJ ;
KOBILKA, BK .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (22) :7920-7924
[10]  
GREEN SA, 1992, MOL PHARMACOL, V41, P889